The budgets of operations and statistical centers of adult clinical trials groups were cut by about $20.4 million, group chairs say.
A study by a conservative think tank found large differences in performance of the FDA divisions, with oncology demonstrating the agency's fastest time from application submission to approval.
The overall economic return from the Women's Health Initiative estrogen plus progestin trial indicates that the changes in practice it produced provided a net economic return of $37.1 billion over 10 years.
The growth of global spending on oncology medicines has slowed over the past five years, according to a report by the IMS Institute for Healthcare Informatics.
National coverage for low-dose computed tomography may result in more harm than benefit to the Medicare population at this time, said Steven Woolf, a member of the Medicare Evidence Development & Coverage Advisory Committee.
When it appeared that CT screening for lung cancer was a shoo-in for Medicare coverage, the Lung Cancer Alliance, an advocacy group, started to certify “screening centers of excellence.”
Panel: Is It Really Up to LCA to Certify Centers?Moments before the hearing was closed to public comments, guest committee member Michael Gould asked Fenton-Ambrose to describe LCA's certification program for screening centers:
An advisory panel for the Centers for Medicare and Medicaid Services expressed low confidence in low-dose computed tomography as a method for screening for lung cancer in the Medicare population.
Knight's $500 Million GiftDruker has been talking about this approach to diagnostics for at least a decade.
